Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Tissue-engineered blood vessel substitute by reconstruction of endothelium using mesenchymal stem cells induced by platelet growth factors

Full text
Author(s):
Bertanha, Matheus [1, 2] ; Moroz, Andrei [2, 3] ; Almeida, Rodrigo [2] ; Alves, Flavia Cilene [2] ; Valerio, Michele Janegitz Acorci [2] ; Moura, Regina [1] ; Domingues, Maria Aparecida Custodio [4] ; Sobreira, Marcone Lima [1] ; Deffune, Elenice [2, 5]
Total Authors: 9
Affiliation:
[1] UNESP Paulista State Univ, Botucatu Med Sch, Dept Surg & Orthoped, Vasc Lab, BR-18618970 Botucatu, SP - Brazil
[2] UNESP Paulista State Univ, Botucatu Med Sch, Cell Engn Lab, Ctr Blood Transfus, BR-18618970 Botucatu, SP - Brazil
[3] UNESP Paulista State Univ, Dept Morphol, Extracellular Matrix Lab, Botucatu Biosci Inst, BR-18618970 Botucatu, SP - Brazil
[4] UNESP Paulista State Univ, Botucatu Med Sch, Dept Pathol, BR-18618970 Botucatu, SP - Brazil
[5] UNESP Paulista State Univ, Botucatu Med Sch, Dept Urol, BR-18618970 Botucatu, SP - Brazil
Total Affiliations: 5
Document type: Journal article
Source: JOURNAL OF VASCULAR SURGERY; v. 59, n. 6, p. 1677-1685, JUN 2014.
Web of Science Citations: 10
Abstract

Background: Cardiovascular diseases remain leaders as the major causes of mortality in Western society. Restoration of the circulation through construction of bypass surgical treatment is regarded as the gold standard treatment of peripheral vascular diseases, and grafts are necessary for this purpose. The great saphenous vein is often not available and synthetic grafts have their limitations. Therefore, new techniques to produce alternative grafts have been developed and, in this sense, tissue engineering is a promising alternative to provide biocompatible grafts. This study objective was to reconstruct the endothelium layer of decellularized vein scaffolds, using mesenchymal stem cells (MSCs) and growth factors obtained from platelets. Methods: Fifteen nonpregnant female adult rabbits were used for all experiments. Adipose tissue and vena cava were obtained and subjected to MSCs isolation and tissue decellularization, respectively. MSCs were subjected to differentiation using endothelial inductor growth factor (EIGF) obtained from human platelet lysates. Immunofluorescence, histological and immunohistochemical analyses were employed for the final characterization of the obtained blood vessel substitute. Results: The scaffolds were successfully decellularized with sodium dodecyl sulfate. MSCs actively adhered at the scaffolds, and through stimulation with EIGF were differentiated into functional endothelial cells, secreting significantly higher quantities of von Willebrand factor (0.85 mu g/mL; P < .05) than cells cultivated under the same conditions, without EIGF (0.085 mu g/mL). Cells with evident morphologic characteristics of endothelium were seen at the lumen of the scaffolds. These cells also stained positive for fascin protein, which is highly expressed by differentiated endothelial cells. Conclusions: Taken together, the use of decellularized bioscaffold and subcutaneous MSCs seems to be a potential approach to obtain bioengineered blood vessels, in the presence of EIGF supplementation. (AU)

FAPESP's process: 13/12614-3 - Tissue-engineered blood vessel substitute by reconstruction of endothelium using mesenchymal stem cells induced by platelet growth factors
Grantee:Marcone Lima Sobreira
Support type: Regular Research Grants - Publications - Scientific article